Literature DB >> 7503553

Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage.

R Schneiderman1, N Rosenberg, J Hiss, P Lee, F Liu, R L Hintz, A Maroudas.   

Abstract

The concentration of free insulin-like growth Factor-I (IGF-I) and its complexes was determined in human normal and osteoarthritic synovial fluids, using ultrafiltration through 20- and 100-kDa membranes, followed by a radioimmunoassay of each fraction. In addition, freshly obtained samples of normal and osteoarthritic cartilage were incubated for several days, at both 4 and 37 degrees C. The incubation media (desorbates) were analyzed the same way as the synovial fluid samples to yield the concentration of IGF-I in cartilage in situ. Our findings are (i) Free IGF-I content is extremely low in both human serum and synovial fluid and there is no significant difference between the two; (ii) The concentration of total IGF-I in normal human synovial fluid is an order of magnitude lower than that in serum due mainly to the decrease in the concentration of the large complex; (iii) Preliminary results show that the total IGF-I in osteoarthritic synovial fluids is twice as high as in normal fluids; (iv) In normal human cartilage the levels of IGF-I in all its forms are very low and are consistent with the expected exclusion of large molecules by the extracellular matrix; (v) By contrast, in osteoarthritic cartilage, the concentrations of all forms of IGF-I are high, probably due to increased permeability of the matrix and binding; (vi) The levels of IGF-I found in normal human cartilage are more than an order of magnitude lower than those which stimulate proteoglycan synthesis in human cartilage in culture, while the IGF-I levels in osteoarthritic cartilage lie in the range in which stimulation does occur.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503553     DOI: 10.1006/abbi.1995.9913

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

1.  Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.

Authors:  Rachel E Miller; Alan J Grodzinsky; Kiersten Cummings; Anna H K Plaas; Ada A Cole; Richard T Lee; Parth Patwari
Journal:  Arthritis Rheum       Date:  2010-12

2.  Basic fibroblast growth factor inhibits the anabolic activity of insulin-like growth factor 1 and osteogenic protein 1 in adult human articular chondrocytes.

Authors:  Richard F Loeser; Susan Chubinskaya; Carol Pacione; Hee-Jeong Im
Journal:  Arthritis Rheum       Date:  2005-12

3.  Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold.

Authors:  Leanne M Mullen; Serena M Best; Roger A Brooks; Siddhartha Ghose; Jessica H Gwynne; John Wardale; Neil Rushton; Ruth E Cameron
Journal:  Tissue Eng Part C Methods       Date:  2010-05-22       Impact factor: 3.056

4.  Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads.

Authors:  S Chubinskaya; A Hakimiyan; C Pacione; A Yanke; L Rappoport; T Aigner; D C Rueger; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2006-11-27       Impact factor: 6.576

5.  Regulation of immature cartilage growth by IGF-I, TGF-beta1, BMP-7, and PDGF-AB: role of metabolic balance between fixed charge and collagen network.

Authors:  Anna Asanbaeva; Koichi Masuda; Eugene J-M A Thonar; Stephen M Klisch; Robert L Sah
Journal:  Biomech Model Mechanobiol       Date:  2007-08-29

6.  Insulin-like growth factor I gene promoter polymorphism, collagen type II alpha1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study.

Authors:  G Zhai; F Rivadeneira; J J Houwing-Duistermaat; I Meulenbelt; C Bijkerk; A Hofman; J B J van Meurs; A G Uitterlinden; H A P Pols; P E Slagboom; C M van Duijn
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

7.  Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice.

Authors:  S Nuka; W Zhou; S P Henry; C M Gendron; J B Schultz; T Shinomura; J Johnson; Y Wang; D R Keene; R Ramírez-Solis; R R Behringer; M F Young; M Höök
Journal:  Osteoarthritis Cartilage       Date:  2009-11-18       Impact factor: 6.576

8.  Persisting high levels of synovial fluid markers after cartilage repair: a pilot study.

Authors:  Anna I Vasara; Yrjö T Konttinen; Lars Peterson; Anders Lindahl; Ilkka Kiviranta
Journal:  Clin Orthop Relat Res       Date:  2008-08-15       Impact factor: 4.176

9.  Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) is closely associated with the chondrocyte nucleus in human articular cartilage.

Authors:  E B Hunziker; E Kapfinger; J Martin; J Buckwalter; T I Morales
Journal:  Osteoarthritis Cartilage       Date:  2007-08-13       Impact factor: 6.576

10.  The quantitative and functional relation between insulin-like growth factor-I (IGF) and IGF-binding proteins during human osteoarthritis.

Authors:  Teresa I Morales
Journal:  J Orthop Res       Date:  2008-04       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.